Regulation of Allergies Across the Body by Microbial Metabolites

The rising incidence of food allergies is a significant public health concern, particularly in developed nations. Affecting an estimated 5% to 8% of the population, with variations based on country and age, food allergies are more prevalent in children, highlighting the critical role of immune system development, diet, and the gut microbiome . These allergies manifest as immune overreactions to dietary proteins, commonly triggered by foods like peanuts, tree nuts, milk, eggs, wheat, soy, sesame, crab, and shrimp , impacting the gastrointestinal tract, respiratory system, and skin.

The Immune Response and Microbial Influence

Food allergies are largely attributed to an exaggerated type 2 immune response, involving T-helper 2 (Th2) cells, immunoglobulin E (IgE) production, and mast cell activation . Compromised epithelial barriers in the gut and skin contribute to this process, increasing lymphocyte activation upon exposure to food antigens. Recent research emphasizes the crucial role of microbial metabolites, particularly short-chain fatty acids (SCFAs), in modulating these responses.

Short-Chain Fatty Acids (SCFAs): A Protective Role

Reduced levels of SCFAs, especially butyrate, during early life are linked to an increased risk of food allergies. Butyrate strengthens intestinal barrier function by mitigating Notch signaling, preserving tight junction integrity, and reducing mucosal permeability. Studies in mice demonstrate that butyrate supplementation can reduce anaphylactic reactions . Analysis of fecal samples reveals lower SCFA levels in individuals with food allergies. Prevotella copri, a producer of acetate and propionate, is more abundant in healthy individuals, and its proliferation is encouraged by high-fiber diets, underscoring the diet-microbiome-immune axis.

Butyrate also influences innate immunity by inhibiting IgE-mediated mast cell degranulation through epigenetic mechanisms, downregulating key signaling molecules like Bruton tyrosine kinase (BTK), spleen tyrosine kinase (SYK), and linker for activation of T cells (LAT). Butyrate engages the G protein-coupled receptor GPR109A on mast cells, increasing prostaglandin E2 (PGE2) synthesis, which suppresses mast cell responses.

Indole Metabolites and Immune Homeostasis

Indole metabolites, derived from microbial metabolism of tryptophan, also play a role in immunomodulation. Bifidobacterium breve M-16V elevates levels of indole-3-propionic acid (IPA), activating the aryl hydrocarbon receptor (AhR) and attenuating cow’s milk allergy symptoms. Dietary indole-3-carbinol (I3C), found in cruciferous vegetables, decreases allergen-specific IgG1 levels and mitigates peanut allergy symptoms in experimental models.

Bile Acids: A Complex Role

While SCFAs and indoles generally promote immune tolerance, primary bile acids like chenodeoxycholic acid may exacerbate food allergen sensitization by stimulating retinoic acid-responsive genes and enhancing IgE and IgG1 antibody production. The interplay between bile acid signaling and retinoic acid metabolism is an emerging area of research.

Bile Acids and Oral Immunotherapy

Interestingly, bile acid profiles influence oral immunotherapy for peanut allergies. Combinations of primary and secondary bile acids support the expansion of colonic FOXP3-positive Treg cells, which suppress inflammation and bolster immune tolerance. Pre-treatment fecal bile acid profiles can even predict patient responsiveness to peanut oral immunotherapy; elevated amino acid metabolism, depleting amino acid-conjugated secondary bile acids, correlates with treatment failure, while higher levels of bile acid-producing bacteria like Ruminococcus gnavus are linked to favorable responses.

Future Directions

The dynamic interplay between SCFAs, indoles, and bile acids reveals a sophisticated network influencing food allergy development and treatment. Further research is needed to understand the molecular mechanisms underlying these interactions, paving the way for microbiota-targeted therapies and personalized treatments to induce durable tolerance. Harnessing the protective features of microbial metabolites holds immense potential for reducing the prevalence and severity of allergic disorders .